Role of Genetics in the Diagnosis and Prognosis of Crohn's Disease

Overview

Journal World J Gastroenterol

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2012 Jan 19

PMID 22253516

Citations 29

Authors

Epameinondas V Tsianos

Konstantinos H Katsanos

Vasileios E Tsianos

Affiliations

Soon will be listed here.

Abstract

Considering epidemiological, genetic and immunological data, we can conclude that the inflammatory bowel diseases are heterogeneous disorders of multifactorial etiology in which hereditability and environment interact to produce the disease. It is probable that patients have a genetic predisposition for the development of the disease coupled with disturbances in immunoregulation. Several genes have been so far related to the diagnosis of Crohn's disease. Those genes are related to innate pattern recognition receptors, to epithelial barrier homeostasis and maintenance of epithelial barrier integrity, to autophagy and to lymphocyte differentiation. So far, the most strong and replicated associations with Crohn's disease have been done with NOD2, IL23R and ATG16L1 genes. Many genes have so far been implicated in prognosis of Crohn's disease and many attempts have been made to classify genetic profiles in Crohn's disease. CARD15 seems not only a susceptibility gene, but also a disease-modifier gene for Crohn's disease. Enriching our understanding on Crohn's disease genetics is important but when combining genetic data with functional data the outcome could be of major importance to clinicians.

Citing Articles

Enkephalins and Pain Modulation: Mechanisms of Action and Therapeutic Perspectives.

Garcia-Dominguez M Biomolecules. 2024; 14(8).

PMID: 39199314 PMC: 11353043. DOI: 10.3390/biom14080926.

Amyloid, Crohn's disease, and Alzheimer's disease - are they linked?.

Duda-Madej A, Stecko J, Szymanska N, Mietkiewicz A, Szandruk-Bender M Front Cell Infect Microbiol. 2024; 14:1393809.

PMID: 38779559 PMC: 11109451. DOI: 10.3389/fcimb.2024.1393809.

Leukocytoclastic Vasculitis and Myositis as Initial Manifestations of Crohn's Disease.

Torere B, Aiwuyo H, Kennard J Cureus. 2023; 14(12):e33127.

PMID: 36721609 PMC: 9884403. DOI: 10.7759/cureus.33127.

Current and projected incidence trends of pediatric-onset inflammatory bowel disease in Germany based on the Saxon Pediatric IBD Registry 2000-2014 -a 15-year evaluation of trends.

Kern I, Schoffer O, Richter T, Kiess W, Flemming G, Winkler U PLoS One. 2022; 17(9):e0274117.

PMID: 36084003 PMC: 9462751. DOI: 10.1371/journal.pone.0274117.

A Review of Hyperbaric Oxygen Therapy for Inflammatory Bowel Disease.

Alenazi N, Alsaeed H, Alsulami A, Alanzi T Int J Gen Med. 2021; 14:7099-7105.

PMID: 34729019 PMC: 8554584. DOI: 10.2147/IJGM.S336678.

References

Watanabe T, Kitani A, Strober W . NOD2 regulation of Toll-like receptor responses and the pathogenesis of Crohn's disease. Gut. 2005; 54(11):1515-8. PMC: 1774769. DOI: 10.1136/gut.2005.071795. View

Akolkar P, Heresbach D, Lin X, Fisher S, Katz S, Silver J . Differences in risk of Crohn's disease in offspring of mothers and fathers with inflammatory bowel disease. Am J Gastroenterol. 1997; 92(12):2241-4. View

Xiao T . Subversion of innate immune signaling through molecular mimicry. J Clin Immunol. 2010; 30(5):638-42. PMC: 2946320. DOI: 10.1007/s10875-010-9435-0. View

Kaser A, Blumberg R . Adaptive immunity in inflammatory bowel disease: state of the art. Curr Opin Gastroenterol. 2008; 24(4):455-61. DOI: 10.1097/MOG.0b013e328304d60d. View

Paradee W, Mullins C, He Z, Glover T, Wilke C, Opalka B . Precise localization of aphidicolin-induced breakpoints on the short arm of human chromosome 3. Genomics. 1995; 27(2):358-61. DOI: 10.1006/geno.1995.1057. View

Gazouli M, Pachoula I, Panayotou I, Mantzaris G, Chrousos G, Anagnou N . NOD2/CARD15, ATG16L1 and IL23R gene polymorphisms and childhood-onset of Crohn's disease. World J Gastroenterol. 2010; 16(14):1753-8. PMC: 2852824. DOI: 10.3748/wjg.v16.i14.1753. View

Pierik M, Vermeire S, Steen K, Joossens S, Claessens G, Vlietinck R . Tumour necrosis factor-alpha receptor 1 and 2 polymorphisms in inflammatory bowel disease and their association with response to infliximab. Aliment Pharmacol Ther. 2004; 20(3):303-10. DOI: 10.1111/j.1365-2036.2004.01946.x. View

Beckly J, Hancock L, Geremia A, Cummings J, Morris A, Cooney R . Two-stage candidate gene study of chromosome 3p demonstrates an association between nonsynonymous variants in the MST1R gene and Crohn's disease. Inflamm Bowel Dis. 2008; 14(4):500-7. DOI: 10.1002/ibd.20365. View

Franke A, Fischer A, Nothnagel M, Becker C, Grabe N, Till A . Genome-wide association analysis in sarcoidosis and Crohn's disease unravels a common susceptibility locus on 10p12.2. Gastroenterology. 2008; 135(4):1207-15. DOI: 10.1053/j.gastro.2008.07.017. View

10.

Koslowski M, Kubler I, Chamaillard M, Schaeffeler E, Reinisch W, Wang G . Genetic variants of Wnt transcription factor TCF-4 (TCF7L2) putative promoter region are associated with small intestinal Crohn's disease. PLoS One. 2009; 4(2):e4496. PMC: 2637978. DOI: 10.1371/journal.pone.0004496. View

11.

Dambacher J, Staudinger T, Seiderer J, Sisic Z, Schnitzler F, Pfennig S . Macrophage migration inhibitory factor (MIF) -173G/C promoter polymorphism influences upper gastrointestinal tract involvement and disease activity in patients with Crohn's disease. Inflamm Bowel Dis. 2007; 13(1):71-82. DOI: 10.1002/ibd.20008. View

12.

Kugathasan S, Collins N, Maresso K, Hoffmann R, Stephens M, Werlin S . CARD15 gene mutations and risk for early surgery in pediatric-onset Crohn's disease. Clin Gastroenterol Hepatol. 2004; 2(11):1003-9. DOI: 10.1016/s1542-3565(04)00452-5. View

13.

Storr M, Emmerdinger D, Diegelmann J, Pfennig S, Ochsenkuhn T, Goke B . The cannabinoid 1 receptor (CNR1) 1359 G/A polymorphism modulates susceptibility to ulcerative colitis and the phenotype in Crohn's disease. PLoS One. 2010; 5(2):e9453. PMC: 2829088. DOI: 10.1371/journal.pone.0009453. View

14.

Barreiro M, Nunez C, Dominguez-Munoz J, Lorenzo A, Barreiro F, Potel J . Association of NOD2/CARD15 mutations with previous surgical procedures in Crohn's disease. Rev Esp Enferm Dig. 2005; 97(8):547-53. DOI: 10.4321/s1130-01082005000800002. View

15.

Rodriguez-Perez N, Aguinaga-Barrilero A, Gorrono-Echebarria M, Perez-Blas M, Martin-Villa J . Analysis of Crohn's disease-related CARD15 polymorphisms in Spanish patients with idiopathic uveitis. Dis Markers. 2008; 24(2):111-7. PMC: 3850619. DOI: 10.1155/2008/146851. View

16.

Willot S, Vermeire S, Ohresser M, Rutgeerts P, Paintaud G, Belaiche J . No association between C-reactive protein gene polymorphisms and decrease of C-reactive protein serum concentration after infliximab treatment in Crohn's disease. Pharmacogenet Genomics. 2005; 16(1):37-42. DOI: 10.1097/01.fpc.0000182776.57437.d8. View

17.

Klein W, Tromm A, Folwaczny C, Hagedorn M, Duerig N, Epplen J . A polymorphism of the NFKBIA gene is associated with Crohn's disease patients lacking a predisposing allele of the CARD15 gene. Int J Colorectal Dis. 2003; 19(2):153-6. DOI: 10.1007/s00384-003-0531-y. View

18.

Krupoves A, Seidman E, Mack D, Israel D, Morgan K, Lambrette P . Associations between ABCB1/MDR1 gene polymorphisms and Crohn's disease: a gene-wide study in a pediatric population. Inflamm Bowel Dis. 2008; 15(6):900-8. DOI: 10.1002/ibd.20849. View

19.

Friedrichs F, Henckaerts L, Vermeire S, Kucharzik T, Seehafer T, Moller-Krull M . The Crohn's disease susceptibility gene DLG5 as a member of the CARD interaction network. J Mol Med (Berl). 2008; 86(4):423-32. DOI: 10.1007/s00109-008-0307-5. View

20.

Amre D, Mack D, Morgan K, Israel D, Deslandres C, Seidman E . Susceptibility loci reported in genome-wide association studies are associated with Crohn's disease in Canadian children. Aliment Pharmacol Ther. 2010; 31(11):1186-91. DOI: 10.1111/j.1365-2036.2010.04294.x. View